Biomerica Inc (BMRA) 0.9800 $BMRA Biomerica Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biomerica Inc (BMRA) 0.9800 $BMRA

Biomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market
Marketwired - Mon Jul 06, 7:18AM CDT
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, will hold a conference call to discuss its product and recent developments in the Irritable Bowel Syndrome (IBS) market on Wednesday, July 8 at 1:30 pm Pacific Time (4:30 Eastern Time). The call will be hosted by Zack Irani-Cohen, Biomerica's Chief Executive Officer.

Biomerica reports new distribution channel in Brazil upon ANVISA approvals
M2 - Tue Jun 30, 6:06AM CDT
Biomedical company Biomerica (OTCBB:BMRA) disclosed on Monday the receipt of its first Brazilian ANVISA approvals for several of its clinical lab products.

Biomerica Announces Its First Brazilian ANVISA Approvals and a New Distribution Channel in Brazil
Marketwired - Mon Jun 29, 7:19AM CDT
Biomerica, Inc. (OTCBB: BMRA) today announced that it received its first Brazilian ANVISA approvals for several of its clinical lab products. ANVISA is Brazil's equivalent to the US FDA, and is responsible for the oversight of all pharmaceuticals and medical devices in the Brazilian market. The approved products will be distributed through a new Brazilian distribution partner. Several other Biomerica product approvals are pending.

Global Rapid Medical Diagnostic Kits Market - Applications and Technologies Analysis of the $27 Billion Industry
M2 - Mon May 25, 10:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v48zr8/global_rapid) has announced the addition of the "Global Rapid Medical Diagnostic Kits Market - Applications and Technologies" report to their offering. lobal market for Rapid Medical Diagnostic Kits, estimated at US$19.4 billion in 2014, forecast at US$20.4 billion in 2015 and further expected to maintain a CAGR of 5.7% between 2014 and 2020 to reach a projected US$27 billion by 2020. The global market for Rapid Medical Diagnostic Kits (MDKs) has been witnessing steady, albeit not rapidly accelerated, growth over the past few years, and this trend is likely to sustain over the coming years. One of the major factors that can be attributed to this is the quick time, typically inside of 30 minutes, within which test results can be made available. This helps physicians in expediting the therapy process for individuals by prescribing the appropriate medications within a short period of time. Gone are the days when doctors had to rely on out-of-office laboratories, which more often than not took days, if not weeks, in processing and providing test results. Now, a clinical test using a sample from the patient can be performed within a physician's office, the specimen sent to an in-house laboratory and results obtained while the patient waits. Worldwide market for Rapid Medical Diagnostic Kits application segments explored in this study includes Clinical Testing, Home-Based Testing and Veterinary Testing. These broader application segments further analyzed for the applications areas of Blood Glucose, Cholesterol, Fertility & Pregnancy, Infectious Disease and Substance Abuse. The report also focuses on the technologies of Rapid Medical Diagnostic Kits comprising Agglutination, Flow-Through, Lateral Flow and Solid-Phase. The global markets for the above mentioned application segments and diagnostic technologies are analyzed in terms of USD. G This report reviews, analyses and projects the Rapid Medical Diagnostic Kits market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - France, Germany, Italy, Spain and the United Kingdom; Asia-Pacific -China, India, Japan and South Korea; South America - Argentina and Brazil. This report profiles 42 key global players and 55 major players across North America - 39; Europe - 7; and Asia-Pacific - 9. The research also provides the listing of the companies engaged in manufacturing and supply of Rapid MDKs. The global list of companies covers addresses, contact numbers and the website addresses of 193 companies. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. South America 5. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part D: Annexure 1. Research Methodology 2. Feedback Companies Mentioned - Abbott Laboratories, Inc - Alfa Scientific Designs, Inc - Arkray USA Inc - Beckman Coulter Inc - Becton, Dickinson And Company - Biomerica, Inc - Biom?rieux SA - Bio-Rad Laboratories, Inc - Diagnostic Automation / Cortez Diagnostics Inc - EKF Diagnostics Holdings Plc - Enzo Life Sciences, Inc - F. Hoffmann-La Roche Ltd - IDEXX Laboratories, Inc - Immunostics, Inc - Inbios International, Inc - Jant Pharmacal Corporation - Labsystems Diagnostics OY - Lifescan, Inc - Princeton Biomeditech Corporation - Quidel Corporation - Rapid Diagnostic Pvt. Ltd - Roche Diagnostics Corporation - Runbio Biotech Co., Ltd. - SA Scientific, Inc - Sekisui Diagnostics, LLC - Shanghai Kehua Bio-Engineering Co., Ltd (KHB) - Siemens Healthcare - Standard Diagnostics, Inc - Taidoc Technology Corporation - Thermo Fisher Scientific Inc - Zoetis, Inc For more information visit http://www.researchandmarkets.com/research/v4...obal_rapid
ZTS: 46.96 (+0.39), ABT: 49.93 (+0.74), IDXX: 64.09 (+1.22)

Biomerica Announces Third Quarter Financial Results and Establishes Scientific Advisory Board
Marketwired - Wed Apr 15, 7:19AM CDT
Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $3,467,450 for the nine months ending February 28, 2015, compared to $3,441,299 for the same period in the previous year. Sales for the three months ending February 28, 2015 were $1,299,400 compared to $1,492,719 for the same period last year.

Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Report Featuring 75+ Companies Operating in this Market
M2 - Mon Feb 02, 3:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/jkszvl/biomarker) has announced the addition of the "Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Report Featuring 75 Companies Operating in this Market" report to their offering. Biomarker Technology Platforms for Cancer Diagnoses and Therapies Report particularly examines those clinical measurement devices, and their reagents and supplies, which are meant to be used in hospitals, clinics, commercial laboratories and doctor's offices to diagnose and monitor cancer. The examination also provides an in-depth discussion of the application of biomarkers in developing novel targeted cancer therapeutics, their predication response and efficacy, as well as their use in diagnosis of cancer. The purpose of this publications report is to describe the specific segment of the cancer diagnostics market which develops new biomarker technology platforms for diagnosing and treating cancer. Biomarkers are useful in following the course of cancer and evaluating which therapeutic regimes are most effective for a particular type of cancer, as well as determining long-term susceptibility to cancer or recurrence. Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for early detection and screening tests for diseases such as breast, colon, ovarian and lung cancer. In addition, diagnostic measurement of cancer disease progression is essential to successful disease management. For these reasons, development of new and effective biomarkers for cancer detection and diagnosis is central to the cancer problem. The use of nucleic acid biomarker diagnostics have begun to answer these questions. Protein biomarkers are also useful. Key Topics Covered: 1. Overview 2. Introduction to Cancer Biology and the Diagnostic Industry 3. Market Analysis of the Cancer Biomarkers Space 4. Major Clinical Applications of Cancer Biomarkers 5. Breast Cancer 6. Ovarian Cancer 7. Prostate Cancer 8. Bladder Cancer 9. Colorectal Cancer 10. Genetic Diagnostics Set to Revolutionize Cancer Diagnostic Testing 11. Leukemia Biomarkers 12. Lung Cancer 13. Enabling Technologies for Oncology Biomarker Discovery 14. Biomarker Tests Co-Developed with Cancer Therapeutics as Companion Diagnostics 15. Companion Diagnostics and Personalized Medicine: Biology, Approaches, Pipeline and Regulatory Trends 16. Business Trends in the Industry 17. Companies Entering the Cancer Diagnostics Market with Novel Technology Platforms Companies Mentioned: Click below to view full list of companies - Abbott Diagnostics - Affymetrix, Inc. - Agendia BV - Agensys, Inc. (Astellas Pharma US) - Agilent Technologies - Beckman Coulter, Inc. - Biocode Hycel S.A. - BioCurex, Inc. - Biomarker Technologies, LLC - Biomedical Diagnostics, LLC - Biomerica, Inc. - bioM?rieux - Cangen Biotechnologies, Inc. - DRG International, Inc. - EDP Biotech Corporation - Eisai Co., Ltd. - Eli Lilly & Co. - Immunomedics, Inc. - Incyte Pharmaceuticals, Inc. - InterGenetics, Inc. - Ipsogen (Qiagen Marseille) - Mitsubishi Kagaku Medical - MolecularMD - Myriad Genetics, Inc. - Oncothyreon, Inc. (Formerly known as Biomira) - OPKO Health, Inc. - Roche Molecular Diagnostics - SensiGen, LLC (Sequenom Center for Molecular Medicine) - Siemens Healthcare Diagnostics, Inc. - Vermillion, Inc. (Formerly Ciphergen) For more information visit http://www.researchandmarkets.com/research/jkszvl/biomarker
MYGN: 34.32 (+0.82), IMMU: 4.20 (+0.24), A: 39.40 (+0.48), INCY: 108.33 (+0.22), LLY: 88.29 (+0.81), ONTY: 3.66 (+0.04), VRML: 1.96 (+0.04), AFFX: 11.05 (+0.26), SQNM: 2.95 (+0.11), OPK: 16.55 (-0.01)

Biomerica Announces Second Quarter Financial Results
Marketwired - Thu Jan 15, 7:19AM CST
Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,133,600 for the three months ended November 30, 2014, compared to $934,841 for the same period in the previous year, an increase of 21.3%. Net sales were $2,168,050 for the first six months of fiscal 2015 compared to $1,948,580 for the first six months in fiscal 2014, an increase of 11.3% .

Biomerica Has Filed a First Set of Patent Applications With the USPTO for a New Test to Aid in the Treatment of a Gastrointestinal Disorder
Marketwired - Wed Jan 14, 7:19AM CST
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced today that it has filed a first set of patent applications with the U.S. Patent and Trademark Office for a new test intended to aid in the treatment of a specific gastrointestinal disorder.

Biomerica posts higher Q1 net loss of USD219,268
M2 - Fri Oct 17, 7:13AM CDT
Diagnostic products company Biomerica (OTCBB:BMRA) stated on Thursday that its net loss was USD219,268 for the first fiscal quarter ended 31 August 2014.

Biomerica fiscal Q1 results
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 9:00AM CDT


Biomerica Reports First Quarter Results
Marketwired - Thu Oct 16, 7:19AM CDT
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced financial results today for the first fiscal quarter ended August 31, 2014.

Biomerica Announces Year End Results
Marketwire - Tue Sep 02, 6:47AM CDT
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2014 were $5,120,451 versus net sales of $6,472,960 in fiscal 2013. Net loss was $215,660 for fiscal 2014 compared to net income of $536,957 for fiscal 2013. Net sales for the fourth quarter ended May 31, 2014 were $1,679,152 versus net sales of $1,470,542 in the same fiscal quarter 2013. The pre-tax net loss for the fourth quarter fiscal 2014 was $51,423 compared to net income of $19,138 for fiscal 2013. Research and Development spending was $589,866 for fiscal year 2014 compared to $459,086 the previous year, an increase of $130,780.

Biomerica to Supply Its Colorectal Screening Point of Care Test to Multinational Pharmaceutical Company With Over $40 Billion in Sales
Marketwire - Mon Aug 11, 7:19AM CDT
Biomerica, Inc. (OTCBB: BMRA) announced today it will supply its EZ Detect colorectal screening test to a multinational pharmaceutical company that has over $40 billion in revenues and over 70,000 employees worldwide. The EZ Detect product will be sold and marketed by the pharmaceutical company in one European country with the possibility of expanding into multiple other countries throughout Europe. The same pharmaceutical company currently distributes two other Biomerica point of care tests and the colorectal screening test is a new addition to the line. The terms of the agreement were not disclosed and will remain confidential.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 277

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 233

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 0

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Fokus Mining Corporation Pursues $1.5 Million Funding Initiative

Updated Category News Views 194

Fokus Mining Corporation Reveals New Funding Initiative Fokus Mining Corporation (TSX.V: FKM) and OTCQB: FKMCF has announced an exciting plan to raise $1.5 million through a private placement. This move is particularly important as it highlights the company's dedication to advancing its projects and boosting its operational capabilities. Overview of the Private Placement...

Continue Reading
Empowering Investors: Lions Gate Entertainment Corp. Class Action

Updated Category News Views 102

Understanding the Investigation into Lions Gate Entertainment Corp. Lions Gate Entertainment Corp. is facing serious scrutiny due to concerns about possible misrepresentation of crucial business information to shareholders. This situation has sparked a thorough examination of their practices, especially following a recent lawsuit filed against the company. Details of the...

Continue Reading
Revolutionary Tool Simplifies Muriatic Acid Application for Pools

Updated Category News Views 137

Innovative Solution for Pool Maintenance Maintaining a clean and attractive swimming pool is essential for many homeowners. One common challenge faced during pool maintenance is dealing with stubborn stains that can mar the pool's beauty. To address this issue, an inventive mind has introduced a unique tool known as STICK-A-STAIN, designed specifically for applying...

Continue Reading
Landsnet Reports Strong Half-Year Results with Future Growth in Sight

Updated Category News Views 163

Landsnet's Half-Year Financial Performance Overview Landsnet recently released its financial report for the period ending in June 2025, showing noteworthy progress. The company reported a profit of USD 11.5 million, supporting its robust standing in the market. Key Financial Highlights The interim financial results indicate a decrease in profit compared to last year,...

Continue Reading
KabaFusion and Tennr Join Forces to Transform Home Infusion Care

Updated Category News Views 222

KabaFusion and Tennr Join Forces to Transform Home Infusion Care Strategic Partnership Uses AI to Advance Patient Care, Empower Clinicians, and Optimize Home Infusion Services KabaFusion, a leading name in home infusion, has announced its strategic partnership with Tennr, a cutting-edge healthcare technology firm known for automating referral-based care. This...

Continue Reading